MARGARET SCHMIDTLEIN: Open Payments
NPI 1962778407 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,077 in 40 payments from 16 companies in 2025. Trend: 2023 $1,278 · 2024 $802 · 2025 $1,077
Food & beverage: $1,077
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 10 | $187 |
| Gilead Sciences, Inc. | 3 | $175 |
| AstraZeneca Pharmaceuticals LP | 6 | $150 |
| ViiV Healthcare Company | 5 | $125 |
| GlaxoSmithKline, LLC. | 1 | $120 |
| Amgen Inc. | 3 | $80 |
| ABBVIE INC. | 3 | $69 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $26 |
| Collegium Pharmaceutical, Inc. | 1 | $23 |
| Daiichi Sankyo Inc. | 1 | $22 |
Products named: Yeztugo, APRETUDE, AREXVY, NURTEC ODT, KRYSTEXXA, BREZTRI, PREVNAR 20, UBRELVY.
Industry payments across MO — which companies pay providers there.
